{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:17:56Z","timestamp":1772626676655,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"SPARKS Medical Research and Rosetrees Trust","award":["12Liv01"],"award-info":[{"award-number":["12Liv01"]}]},{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"publisher","award":["HC Roscoe-2012"],"award-info":[{"award-number":["HC Roscoe-2012"]}],"id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Biomedical Research Centre","award":["BRC-LivZhang01"],"award-info":[{"award-number":["BRC-LivZhang01"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.028","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T23:41:37Z","timestamp":1456011697000},"page":"1688-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines"],"prefix":"10.1016","volume":"34","author":[{"given":"Jennifer","family":"Mullin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navdeep","family":"Upile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Achar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suttida","family":"Puksuriwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (27)","key":"10.1016\/j.vaccine.2016.02.028_bib0270","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"issue":"November (47\u201348)","key":"10.1016\/j.vaccine.2016.02.028_bib0275","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1016\/j.vaccine.2006.07.042","article-title":"Establishing the health and economic impact of influenza vaccination within the European Union 25 countries","volume":"24","author":"Ryan","year":"2006","journal-title":"Vaccine"},{"issue":"7212","key":"10.1016\/j.vaccine.2016.02.028_bib0280","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2016.02.028_bib0285","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/JVI.02184-09","article-title":"Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses","volume":"84","author":"Krause","year":"2010","journal-title":"J Virol"},{"issue":"April (5976)","key":"10.1016\/j.vaccine.2016.02.028_bib0290","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science"},{"issue":"0","key":"10.1016\/j.vaccine.2016.02.028_bib0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.antiviral.2014.12.008","article-title":"Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection","volume":"114","author":"Ahmed","year":"2015","journal-title":"Antiviral Res"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2016.02.028_bib0300","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/JVI.03547-12","article-title":"Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses","volume":"87","author":"Mahallawi","year":"2013","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.02.028_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA\u2212 NP+ M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2016.02.028_bib0310","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1099\/vir.0.024885-0","article-title":"Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A\/H1N1 vaccine in the ferret model","volume":"91","author":"Kreijtz","year":"2010","journal-title":"J Gen Virol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2016.02.028_bib0315","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/infdis\/jiu654","article-title":"Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children","volume":"211","author":"Mohn","year":"2015","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.028_bib0320","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2016.02.028_bib0325","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.167.6.3293","article-title":"Antigen-specific CD8+ T cells persist in the upper respiratory tract following influenza virus infection","volume":"167","author":"Wiley","year":"2001","journal-title":"J Immunol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2016.02.028_bib0330","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.028_bib0335","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1086\/425517","article-title":"Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults","volume":"190","author":"Guthrie","year":"2004","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.02.028_bib0340","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS ONE"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2016.02.028_bib0345","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/IAI.00590-06","article-title":"A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge","volume":"74","author":"Dunachie","year":"2006","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.028_bib0350","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0355","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2016.02.028_bib0360","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.028_bib0365","doi-asserted-by":"crossref","first-page":"e88340","DOI":"10.1371\/journal.pone.0088340","article-title":"MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses","volume":"9","author":"Hessel","year":"2014","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.028_bib0370","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.70.9.6418-6424.1996","article-title":"Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza","volume":"70","author":"Bender","year":"1996","journal-title":"J Virol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2016.02.028_bib0375","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0264-410X(99)00257-1","article-title":"Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA","volume":"18","author":"Wyatt","year":"1999","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2016.02.028_bib0380","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/INF.0b013e318255e443","article-title":"T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine","volume":"31","author":"Lambe","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.028_bib0385","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/eji.200535101","article-title":"Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status","volume":"36","author":"Zhang","year":"2006","journal-title":"Eur J Immunol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2016.02.028_bib0390","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/512617","article-title":"Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children","volume":"195","author":"Zhang","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0395","article-title":"Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage","author":"Gray","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"March (5665)","key":"10.1016\/j.vaccine.2016.02.028_bib0400","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.1093373","article-title":"Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus","volume":"303","author":"Stevens","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0405","unstructured":"Smith GE, Volvovitz F, Wilkinson BE, Hackett CS. Method for producing influenza hemagglutinin multivalent vaccines using baculovirus. MG-PMC, LLC, assignee. U.S. Patent 5,762,939. 09 June 1998."},{"issue":"8","key":"10.1016\/j.vaccine.2016.02.028_bib0410","doi-asserted-by":"crossref","first-page":"e1002175","DOI":"10.1371\/journal.ppat.1002175","article-title":"Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization","volume":"7","author":"Zhang","year":"2011","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.028_bib0415","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/mi.2013.89","article-title":"Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage","volume":"7","author":"Gray","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.028_bib0420","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel Jason","year":"2014","journal-title":"Immunity"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2016.02.028_bib0425","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.175.7.4355","article-title":"\u03b1E\u03b27 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population","volume":"175","author":"Woodberry","year":"2005","journal-title":"J Immunol"},{"issue":"August (6044)","key":"10.1016\/j.vaccine.2016.02.028_bib0430","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to Group 1 and Group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0435","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4172\/1747-0862.1000056","article-title":"The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses","volume":"7","author":"Molesti","year":"2013","journal-title":"J Mol Genet Med"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0440","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4172\/1747-0862.1000055","article-title":"The human transmembrane protease serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes","volume":"7","author":"Ferrara","year":"2013","journal-title":"J Mol Genet Med"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.028_bib0445","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"Temperton","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2016.02.028_bib0450","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.028_bib0455","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0705191105","article-title":"Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic","volume":"105","author":"Corbett","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.028_bib0460","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","article-title":"Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration","volume":"148","author":"Ramirez","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-1-10","article-title":"Susceptibility of different leukocyte cell types to vaccinia virus infection","volume":"1","author":"Sanchez-Puig","year":"2004","journal-title":"Virol J"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2016.02.028_bib0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-1759(98)00156-2","article-title":"Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry","volume":"220","author":"Dominguez","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0475","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2172-9-15","article-title":"Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo","volume":"9","author":"Liu","year":"2008","journal-title":"BMC Immunol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2016.02.028_bib0480","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.4049\/jimmunol.176.4.2122","article-title":"Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response","volume":"176","author":"Shimoda","year":"2006","journal-title":"J Immunol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2016.02.028_bib0485","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"Brandler","year":"2010","journal-title":"J Virol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2016.02.028_bib0490","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2016.02.028_bib0495","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"issue":"April (5924)","key":"10.1016\/j.vaccine.2016.02.028_bib0500","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.028_bib0505","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.028_bib0510","doi-asserted-by":"crossref","first-page":"e1000745","DOI":"10.1371\/journal.ppat.1000745","article-title":"Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines","volume":"6","author":"Manicassamy","year":"2010","journal-title":"PLoS Pathog"},{"issue":"23","key":"10.1016\/j.vaccine.2016.02.028_bib0515","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.028_bib0520","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0525","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","author":"Pica","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2016.02.028_bib0530","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:14:20Z","timestamp":1600208060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001705"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}